To reinforce this observation, cross-validation analyses through two independent public platforms (TIMER and GEPIA) revealed a robust correlation between SREBP2 and SORT1 expression in HCC cohorts (Supplementary Fig. 3F, H). The gene discussed is SREBF2; the disease is hepatocellular carcinoma.